Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

ClinicalTrials.gov ID: NCT00598442

Public ClinicalTrials.gov record NCT00598442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AFX01-13: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to evaluate the safety and efficacy of peginesatide for the treatment of anemia in participants with chronic kidney disease, who are not on dialysis and not on erythropoiesis stimulating agent (ESA) treatment.

Study identification

NCT ID
NCT00598442
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Affymax
Industry
Enrollment
493 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2007 (Type not available)
Primary completion
Jul 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Feb 12, 2013

2007 – 2009

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
41
Facility City State ZIP Site status
Research Facility Phoenix Arizona 85012 —
Research Facility Fayetteville Arkansas 72703 —
Research Facility Fountain Valley California 92708 —
Research Facility Fullerton California 92835 —
Research Facility Granada Hills California 91344 —
Research Facility Los Angeles California 90022 —
Research Facility San Diego California 92123 —
Research Facility Whittier California 90603 —
Research Facility Lauderdale Lakes Florida 33313 —
Research Facility Pembroke Pines Florida 33028 —
Research Facility Pinecrest Florida 33156 —
Research Facility Canton Georgia 30114 —
Research Facility Columbus Georgia 31904 —
Research Facility Marietta Georgia 30060 —
Research Facility Caldwell Idaho 83605 —
Research Facility Meridian Idaho 83642 —
Research Facility Chicago Illinois 60611 —
Research Facility Mishawaka Indiana 46545 —
Research Facility Ames Iowa 50010 —
Research Facility Baton Rouge Louisiana 70809 —
Research Facility Lafayette Louisiana 70506 —
Research Facility Rockville Maryland 20852 —
Research Facility Springfield Massachusetts 01107 —
Research Facility Detroit Michigan 48202 —
Research Facility Detroit Michigan 48236 —
Research Facility Flint Michigan 48504 —
Research Facility Petoskey Michigan 49770 —
Research Facility Troy Michigan 48098 —
Research Facility Washington Missouri 63090 —
Research Facility Flushing New York 11355 —
Research Facility Williamsville New York 14221 —
Research Facility Asheville North Carolina 28801 —
Research Facility Columbus Ohio 43210 —
Research Facility Bend Oregon 97701 —
Research Facility Arlington Texas 76015 —
Research Facility Houston Texas 77004 —
Research Facility San Antonio Texas 78229 —
Research Facility Burlington Vermont 05401 —
Research Facility Fairfax Virginia 22030 —
Research Facility Tacoma Washington 98405 —
Research Facility Morgantown West Virginia 26506 —
Research Facility Neenah Wisconsin 54956 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00598442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2013 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00598442 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →